Cargando…

Systematic review of model-based cervical screening evaluations

BACKGROUND: Optimising population-based cervical screening policies is becoming more complex due to the expanding range of screening technologies available and the interplay with vaccine-induced changes in epidemiology. Mathematical models are increasingly being applied to assess the impact of cervi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Diana, Bains, Iren, Vanni, Tazio, Jit, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419493/
https://www.ncbi.nlm.nih.gov/pubmed/25924871
http://dx.doi.org/10.1186/s12885-015-1332-8
_version_ 1782369586013798400
author Mendes, Diana
Bains, Iren
Vanni, Tazio
Jit, Mark
author_facet Mendes, Diana
Bains, Iren
Vanni, Tazio
Jit, Mark
author_sort Mendes, Diana
collection PubMed
description BACKGROUND: Optimising population-based cervical screening policies is becoming more complex due to the expanding range of screening technologies available and the interplay with vaccine-induced changes in epidemiology. Mathematical models are increasingly being applied to assess the impact of cervical cancer screening strategies. METHODS: We systematically reviewed MEDLINE®, Embase, Web of Science®, EconLit, Health Economic Evaluation Database, and The Cochrane Library databases in order to identify the mathematical models of human papillomavirus (HPV) infection and cervical cancer progression used to assess the effectiveness and/or cost-effectiveness of cervical cancer screening strategies. Key model features and conclusions relevant to decision-making were extracted. RESULTS: We found 153 articles meeting our eligibility criteria published up to May 2013. Most studies (72/153) evaluated the introduction of a new screening technology, with particular focus on the comparison of HPV DNA testing and cytology (n = 58). Twenty-eight in forty of these analyses supported HPV DNA primary screening implementation. A few studies analysed more recent technologies - rapid HPV DNA testing (n = 3), HPV DNA self-sampling (n = 4), and genotyping (n = 1) - and were also supportive of their introduction. However, no study was found on emerging molecular markers and their potential utility in future screening programmes. Most evaluations (113/153) were based on models simulating aggregate groups of women at risk of cervical cancer over time without accounting for HPV infection transmission. Calibration to country-specific outcome data is becoming more common, but has not yet become standard practice. CONCLUSIONS: Models of cervical screening are increasingly used, and allow extrapolation of trial data to project the population-level health and economic impact of different screening policy. However, post-vaccination analyses have rarely incorporated transmission dynamics. Model calibration to country-specific data is increasingly common in recent studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1332-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4419493
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44194932015-05-06 Systematic review of model-based cervical screening evaluations Mendes, Diana Bains, Iren Vanni, Tazio Jit, Mark BMC Cancer Research Article BACKGROUND: Optimising population-based cervical screening policies is becoming more complex due to the expanding range of screening technologies available and the interplay with vaccine-induced changes in epidemiology. Mathematical models are increasingly being applied to assess the impact of cervical cancer screening strategies. METHODS: We systematically reviewed MEDLINE®, Embase, Web of Science®, EconLit, Health Economic Evaluation Database, and The Cochrane Library databases in order to identify the mathematical models of human papillomavirus (HPV) infection and cervical cancer progression used to assess the effectiveness and/or cost-effectiveness of cervical cancer screening strategies. Key model features and conclusions relevant to decision-making were extracted. RESULTS: We found 153 articles meeting our eligibility criteria published up to May 2013. Most studies (72/153) evaluated the introduction of a new screening technology, with particular focus on the comparison of HPV DNA testing and cytology (n = 58). Twenty-eight in forty of these analyses supported HPV DNA primary screening implementation. A few studies analysed more recent technologies - rapid HPV DNA testing (n = 3), HPV DNA self-sampling (n = 4), and genotyping (n = 1) - and were also supportive of their introduction. However, no study was found on emerging molecular markers and their potential utility in future screening programmes. Most evaluations (113/153) were based on models simulating aggregate groups of women at risk of cervical cancer over time without accounting for HPV infection transmission. Calibration to country-specific outcome data is becoming more common, but has not yet become standard practice. CONCLUSIONS: Models of cervical screening are increasingly used, and allow extrapolation of trial data to project the population-level health and economic impact of different screening policy. However, post-vaccination analyses have rarely incorporated transmission dynamics. Model calibration to country-specific data is increasingly common in recent studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1332-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-05-01 /pmc/articles/PMC4419493/ /pubmed/25924871 http://dx.doi.org/10.1186/s12885-015-1332-8 Text en © Mendes et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mendes, Diana
Bains, Iren
Vanni, Tazio
Jit, Mark
Systematic review of model-based cervical screening evaluations
title Systematic review of model-based cervical screening evaluations
title_full Systematic review of model-based cervical screening evaluations
title_fullStr Systematic review of model-based cervical screening evaluations
title_full_unstemmed Systematic review of model-based cervical screening evaluations
title_short Systematic review of model-based cervical screening evaluations
title_sort systematic review of model-based cervical screening evaluations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419493/
https://www.ncbi.nlm.nih.gov/pubmed/25924871
http://dx.doi.org/10.1186/s12885-015-1332-8
work_keys_str_mv AT mendesdiana systematicreviewofmodelbasedcervicalscreeningevaluations
AT bainsiren systematicreviewofmodelbasedcervicalscreeningevaluations
AT vannitazio systematicreviewofmodelbasedcervicalscreeningevaluations
AT jitmark systematicreviewofmodelbasedcervicalscreeningevaluations